A combinatorial extracellular matrix platform identifies cell-extracellular matrix interactions that correlate with metastasis
暂无分享,去创建一个
Sangeeta N. Bhatia | Nathan E. Reticker-Flynn | Monte M. Winslow | Richard O. Hynes | T. Jacks | S. Bhatia | R. Hynes | M. Winslow | M. Xu | N. E. Reticker-Flynn | G. Underhill | David F. Braga Malta | John M. Lamar | Gregory H. Underhill | Mary J. Xu | Tyler E. Jacks | N. Reticker-Flynn
[1] B. Garmy-Susini,et al. Integrins in angiogenesis and lymphangiogenesis , 2008, Nature Reviews Cancer.
[2] R. Dhir,et al. Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion. , 2010, Cancer research.
[3] C. Fombrun,et al. Matrix , 1979, Encyclopedic Dictionary of Archaeology.
[4] Edi Brogi,et al. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs , 2011, Nature Medicine.
[5] T. Barrette,et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. , 2004, Neoplasia.
[6] Richard O. Hynes,et al. The Extracellular Matrix: Not Just Pretty Fibrils , 2009, Science.
[7] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[8] Y. Takenaka,et al. Galectin-3 and metastasis , 2004, Glycoconjugate Journal.
[9] T. Jacks,et al. Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase , 2009, Nature Protocols.
[10] Lu-Gang Yu. The oncofetal Thomsen–Friedenreich carbohydrate antigen in cancer progression , 2007, Glycoconjugate Journal.
[11] Jeffrey T. Chang,et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies , 2006, Nature.
[12] W. V. van IJcken,et al. Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction , 2010, PloS one.
[13] Derek Y. Chiang,et al. Suppression of Lung Adenocarcinoma Progression by Nkx2-1 , 2011, Nature.
[14] K. L. Woodward,et al. A question of life or death. , 2001, Newsweek.
[15] Shu Chien,et al. Investigating the role of the extracellular environment in modulating hepatic stellate cell biology with arrayed combinatorial microenvironments. , 2009, Integrative biology : quantitative biosciences from nano to macro.
[16] Van,et al. A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.
[17] Mikala Egeblad,et al. Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.
[18] Richard O Hynes,et al. Integrins Bidirectional, Allosteric Signaling Machines , 2002, Cell.
[19] S. Bhatia,et al. An extracellular matrix microarray for probing cellular differentiation , 2005, Nature Methods.
[20] J. Pollard,et al. Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.
[21] W. Muller,et al. Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. , 2004, Cancer cell.
[22] E. Vokes,et al. Phase II study of oxaliplatin (O) and paclitaxel (T) in advanced Non-Small Cell Lung Cancer (NSCLC) , 2000 .
[23] Stephen Pulman,et al. Building the Framework , 1996 .
[24] R. Hynes,et al. The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain , 2012, Proceedings of the National Academy of Sciences.
[25] T. Jacks,et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. , 2001, Genes & development.
[26] S. Weiss,et al. Membrane Type I Matrix Metalloproteinase Usurps Tumor Growth Control Imposed by the Three-Dimensional Extracellular Matrix , 2003, Cell.
[27] David E. Misek,et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma , 2002, Nature Medicine.
[28] Mina J Bissell,et al. Human mammary progenitor cell fate decisions are products of interactions with combinatorial microenvironments. , 2009, Integrative biology : quantitative biosciences from nano to macro.
[29] Yudong D. He,et al. A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .
[30] Woodward Kl. A question of life or death. , 2001 .
[31] Howard Y. Chang,et al. Modeling inducible human tissue neoplasia identifies an extracellular matrix interaction network involved in cancer progression. , 2009, Cancer cell.
[32] R. Bresalier,et al. Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin 3. , 1998, Gastroenterology.
[33] I Salmon,et al. Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor , 2002, Gut.
[34] T. Jacks,et al. The differential effects of mutant p53 alleles on advanced murine lung cancer. , 2005, Cancer research.
[35] H. Hansen,et al. Lung cancer. , 1990, Cancer chemotherapy and biological response modifiers.
[36] P. Sharp,et al. A system for Cre-regulated RNA interference in vivo , 2008, Proceedings of the National Academy of Sciences.
[37] F. O'Malley,et al. Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[38] M. Eisenstein,et al. Role of galectin-8 as a modulator of cell adhesion and cell growth , 2004, Glycoconjugate Journal.
[39] Steven A. Carr,et al. The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices , 2011, Molecular & Cellular Proteomics.
[40] Anne E Carpenter,et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes , 2006, Genome Biology.
[41] Mary J. C. Hendrix,et al. Reprogramming metastatic tumour cells with embryonic microenvironments , 2007, Nature Reviews Cancer.
[42] R. Weinberg,et al. Systemic Endocrine Instigation of Indolent Tumor Growth Requires Osteopontin , 2008, Cell.
[43] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[44] C. Larabell,et al. Reversion of the Malignant Phenotype of Human Breast Cells in Three-Dimensional Culture and In Vivo by Integrin Blocking Antibodies , 1997, The Journal of cell biology.
[45] David A. Cheresh,et al. Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.
[46] Cheryl Regehr,et al. BUILDING A FRAMEWORK , 2005 .
[47] M. Bissell,et al. Inability of Rous sarcoma virus to cause sarcomas in the avian embryo , 1984, Nature.
[48] M. Cronin,et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.
[49] Daniel G. Anderson,et al. Cell-compatible, multicomponent protein arrays with subcellular feature resolution. , 2008, Small.
[50] Y Iwamoto,et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. , 1987, Cancer research.
[51] Shu Chien,et al. Combinatorial signaling microenvironments for studying stem cell fate. , 2008, Stem cells and development.
[52] Gabriel A. Rabinovich,et al. Galectins as modulators of tumour progression , 2005, Nature Reviews Cancer.
[53] J. Massagué,et al. Cancer Metastasis: Building a Framework , 2006, Cell.
[54] P. Steeg,et al. Metastasis: a therapeutic target for cancer , 2008, Nature Clinical Practice Oncology.
[55] A. Puisieux,et al. Metastasis: a question of life or death , 2006, Nature Reviews Cancer.